Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Shepherd, Stacie Peacock
24  Ergebnisse:
Personensuche X
?
1

A phase 1 study of veliparib (ABT-888) plus weekly carbopla..:

Malhotra, Monica K. ; Pahuja, Shalu ; Kiesel, Brian F....
Breast Cancer Research and Treatment.  198 (2023)  3 - p. 487-498 , 2023
Link: https://doi.org/10.1007/..
 
?
2

CTNI-76. EFFICACY OF BRAF INHIBITOR PLIXORAFENIB (FORE8394)..:

de la Fuente, Macarena ; Butowski, Nicholas ; Taylor, Jennie...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v95-v95 , 2023
Link: https://doi.org/10.1093/..
 
?
3

Overcoming Taxane Resistance: Preclinical and Phase 1 Studi..:

Munster, Pamela N. ; Greenstein, Andrew E. ; Fleming, Gini F....
Clinical Cancer Research.  28 (2022)  15 - p. 3214-3224 , 2022
Link: https://doi.org/10.1158/..
 
?
4

Exposure–response analysis to inform the optimal dose of ve..:

Nuthalapati, Silpa ; Stodtmann, Sven ; Shepherd, Stacie Peacock...
Cancer Chemotherapy and Pharmacology.  84 (2019)  5 - p. 977-986 , 2019
Link: https://doi.org/10.1007/..
 
?
5

A phase 1 dose-escalation study of veliparib with bimonthly..:

Berlin, Jordan ; Ramanathan, Ramesh K. ; Strickler, John H....
British Journal of Cancer.  118 (2018)  7 - p. 938-946 , 2018
Link: https://doi.org/10.1038/..
 
?
6

A phase 1 study of PARP-inhibitor ABT-767 in advanced solid..:

van der Biessen, Diane A. J. ; Gietema, Jourik A. ; de Jonge, Maja J. A....
Investigational New Drugs.  36 (2018)  5 - p. 828-835 , 2018
Link: https://doi.org/10.1007/..
 
?
7

Population pharmacokinetics of ABT-767 in BRCA1 or BRCA2 mu..:

Mittapalli, Rajendar K. ; Nuthalapati, Silpa ; Shepherd, Stacie Peacock.
Cancer Chemotherapy and Pharmacology.  79 (2017)  3 - p. 587-594 , 2017
Link: https://doi.org/10.1007/..
 
?
8

A Phase 1 and Pharmacodynamic Study of Chronically-Dosed, S..:

Manzo, Julia ; Puhalla, Shannon ; Pahuja, Shalu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116722/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Overcoming Taxane Resistance: Preclinical and Phase 1 Studi..:

Munster, Pamela N ; Greenstein, Andrew E ; Fleming, Gini F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662918/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

A phase 1 dose-escalation study of veliparib with bimonthly..:

Berlin, Jordan ; Ramanathan, Ramesh K ; Strickler, John H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933261/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
11

A phase 1 study of PARP-inhibitor ABT-767 in advanced solid..:

van der Biessen, Diane A J ; Gietema, Jourik A ; de Jonge, Maja J A...
https://research.rug.nl/en/publications/c0008f03-8d00-4d9a-8012-89ada7cdc840.  , 2018
Link: https://hdl.handle.net/1..
 
?
12

A phase 1 study of PARP-inhibitor ABT-767 in advanced solid..:

Biessen, A.J. (Diane) van der ; Gietema, J.A. (Jourik) ; Jonge, M.J.A. (Maja) de...
http://repub.eur.nl/pub/110337.  , 2018
Link: http://repub.eur.nl/pub/..
 
?
13

53BP1 as a potential predictor of response in PARP inhibito..:

Hurley, Rachel M. ; Wahner Hendrickson, Andrea E. ; Visscher, Daniel W....
Gynecologic Oncology.  153 (2019)  1 - p. 127-134 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Targeting DNA repair with combination veliparib (ABT-888) a..:

Hussain, Maha ; Carducci, Michael A. ; Slovin, Susan...
Investigational New Drugs.  32 (2014)  5 - p. 904-912 , 2014
Link: https://doi.org/10.1007/..
 
?
15

Carrying the Burden: Perspectives of African American Pasto..:

Green, Melissa A. ; Lucas, Justin ; Hanson, Laura C....
Journal of Religion and Health.  53 (2014)  5 - p. 1382-1397 , 2014
Link: https://www.jstor.org/st..
 
1-15